Loading clinical trials...
Loading clinical trials...
The main study objective is to assess the effect of ACT-709478 in male and female subjects with photosensitive epilepsy following single dose administration
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Idorsia Pharmaceuticals Ltd.
NCT03790137 · Photosensitive Epilepsy
NCT03686033 · Photosensitive Epilepsy
NCT00609245 · Photosensitive Epilepsy
NCT00784212 · Photosensitive Epilepsy
HOSP - Bicêtre Neurologie
Le Kremlin-Bicêtre
Bethel Epilepsy Center, Mara Hospital
Bielefeld
Epilepsy Center Frankfurt
Frankfurt
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions